Pertuzumab and Trastuzumab Injection(Subcutaneous Injection)

Roche Pharma (Schweiz) AG🇨🇳 National Medical Products Administration

Approval Id: 8WHZ1fCFj8w
Approval Number: 国药准字SJ20230019
Generic Name: 帕妥珠曲妥珠单抗注射液(皮下注射)
Generic Name En: Pertuzumab and Trastuzumab Injection(Subcutaneous Injection)
Trade Name: 赫双妥
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 维持剂量(10ml)：帕妥珠单抗600mg与曲妥珠单抗600mg
Reg Date: 2023-12-26
Expired Date: 2028-12-25
Company Name: Roche Pharma (Schweiz) AG
Production Company Name: F. Hoffmann-La Roche Ltd
Company Detail Path: /organization/roche-pharma-schweiz-ag
Production Company Detail Path: /organization/f-hoffmann-la-roche-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 26, 2023

Approval ID

8WHZ1fCFj8w

Type

生物制品